Evidence map›Paper›PMID 28820460›Full record

ArticleInternational journal of molecular sciences2017

Determination of Sphingosine-1-Phosphate in Human Plasma Using Liquid Chromatography Coupled with Q-Tof Mass Spectrometry.

Emmanuel Eroume-A Egom, Ross Fitzgerald, Rebecca Canning, Rebabonye B Pharithi, Colin Murphy, Vincent Maher

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.4field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Emmanuel Eroume-A EgomDepartment of Cardiology, The Adelaide and Meath Hospital Dublin, Incorporating the National Children Hospital, Tallaght, 24 Dublin, Ireland. egom@ectrs.ca.
Ross FitzgeraldInstitute of Technology Tallaght, Blessington Road, Tallaght, 24 Dublin, Ireland. Fitzgerald.ross@gmail.com.
Rebecca CanningInstitute of Technology Tallaght, Blessington Road, Tallaght, 24 Dublin, Ireland. Rebecca.Canning@postgrad.ittdublin.ie.
Rebabonye B PharithiDepartment of Cardiology, The Adelaide and Meath Hospital Dublin, Incorporating the National Children Hospital, Tallaght, 24 Dublin, Ireland. rpharithi@gmail.com.
Colin MurphyInstitute of Technology Tallaght, Blessington Road, Tallaght, 24 Dublin, Ireland. colin.murphy@ittdublin.ie.
Vincent MaherDepartment of Cardiology, The Adelaide and Meath Hospital Dublin, Incorporating the National Children Hospital, Tallaght, 24 Dublin, Ireland. Vincent.Maher@amnch.ie.
Tallaght University Hospital · IE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Evidence suggests that high-density lipoprotein (HDL) components distinct from cholesterol, such as sphingosine-1-phosphate (S1P), may account for the anti-atherothrombotic effects attributed to this lipoprotein. The current method for the determination of plasma levels of S1P as well as levels associated with HDL particles is still cumbersome an assay method to be worldwide practical. Recently, a simplified protocol based on liquid chromatography-tandem mass spectrometry (LC-MS/MS) for the sensitive and specific quantification of plasma levels of S1P with good accuracy has been reported. This work utilized a triple quadrupole (QqQ)-based LC-MS/MS system. Here we adapt that method for the determination of plasma levels of S1P using a quadrupole time of flight (Q-Tof) based LC-MS system. Calibration curves were linear in the range of 0.05 to 2 µM. The lower limit of quantification (LOQ) was 0.05 µM. The concentration of S1P in human plasma was determined to be 1 ± 0.09 µM (

Indexed as

CalibrationChromatography, LiquidHumansLipoproteins, HDLLysophospholipidsReproducibility of ResultsSphingosineTandem Mass SpectrometryLipoproteins, HDLLysophospholipidsSphingosinesphingosine 1-phosphatehigh-density lipoproteinhigh-density lipoprotein (HDL)liquid chromatography-mass spectrometry (LC-MS)liquid chromatography-tandem mass spectrometry (LC-MS/MS)quadrupole time of flight (Q-Tof)sphingosine-1-phosphate (S1P)

Identifiers

PMID28820460
PMCPMC5578187
OpenAlexW2748888219

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.